The application pertains to the development of a novel platform for loading Cannabinoids on Exosomes HERZLIYA, Israel and CALGARY, AB, April 3, 2023 /PRNewswire/ — Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the “Company” or “Innocan”), a leading pharmaceutical…